Medication Monitoring for Breast Cancer

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: San Diego State University

No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this study is to learn about the impact of an integrated medication monitoring system in breast cancer survivors aged 21-70 who are prescribed endocrine therapy. The main question it aims to address is: Does the integrated medication monitoring system improve medication adherence among breast cancer survivors when used over a six-month period? Fifteen English-speaking breast cancer survivors who meet the inclusion criteria will use a combination of smartphone-based ecological momentary assessments, a medication event monitoring system (Wisepill), and a wearable sensor (Fitbit). After 2 months, participants will be provided personalized content to facilitate medication adherence through an app (Digital Trails) and through WisePill. Participants will complete online surveys at baseline, 3 months, and 6 months to assess their experiences and adherence.

Eligibility Criteria

This trial is for English-speaking breast cancer survivors aged 21-70 who are on endocrine therapy. Participants must be willing to use a smartphone-based monitoring system, a medication event monitoring device (Wisepill), and wear a Fitbit for six months.

Inclusion Criteria

Willing and able to use the MM system for 6 months

Able to provide informed consent

Have an iPhone or Android phone

+6 more

Participant Groups

The study tests if an integrated medication monitoring system can improve long-term adherence to prescribed endocrine therapy in breast cancer survivors. It involves using tech tools like apps and wearable sensors over six months, with personalized content provided after two months.

1Treatment groups

Experimental Treatment

Group I: integrated medication monitoring systemExperimental Treatment1 Intervention

The single-arm intervention design of this study focuses on delivering a comprehensive integrated medication monitoring system to a cohort of breast cancer survivors. The system will analyze data collected from EMAs, MEMS, and Fitbit sensors to identify participants at risk of nonadherence. Based on this risk assessment, personalized interventions will be delivered through the Digital Trails app, which may include reminders for medication intake, among others.